Off-Label Info OK: So What?
Executive Summary
One of the most controversial issues coming out of the recently concluded legislative battle over reforming the FDA involved expanding medical companies' abilities to promote off-label uses of their products. Yet in the end, the ultimate impact of this reform appears to be negligible.